These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 19037240
1. Analysis of human immunodeficiency virus type 1 vector cis- and trans-acting elements production by means of Semliki Forest virus. Del Vecchio C, Calistri A, Lombardi G, Celegato M, Biasolo MA, Palù G, Parolin C. Gene Ther; 2009 Feb; 16(2):279-90. PubMed ID: 19037240 [Abstract] [Full Text] [Related]
3. Efficient gene delivery into mammalian cells by recombinant baculovirus containing a hybrid cytomegalovirus promoter/Semliki Forest virus replicon. Pan Y, Zhao Q, Fang L, Luo R, Chen H, Xiao S. J Gene Med; 2009 Nov; 11(11):1030-8. PubMed ID: 19757479 [Abstract] [Full Text] [Related]
4. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. Chang LJ, Urlacher V, Iwakuma T, Cui Y, Zucali J. Gene Ther; 1999 May; 6(5):715-28. PubMed ID: 10505094 [Abstract] [Full Text] [Related]
5. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector. Ni Y, Sun S, Oparaocha I, Humeau L, Davis B, Cohen R, Binder G, Chang YN, Slepushkin V, Dropulic B. J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055 [Abstract] [Full Text] [Related]
6. High cell surface expression of Newcastle disease virus proteins via replicon vectors demonstrates syncytia forming activity of F and fusion promotion activity of HN molecules. Zeng J, Fournier P, Schirrmacher V. Int J Oncol; 2004 Aug; 25(2):293-302. PubMed ID: 15254725 [Abstract] [Full Text] [Related]
7. [Construction of DNA and RNA based on bifunctional replicon vector derived from Semliki Forest virus]. Yu YZ, Sun ZW, Yu WY. Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):713-8. PubMed ID: 16285510 [Abstract] [Full Text] [Related]
8. Mobilization of full-length Semliki Forest virus replicon by retrovirus particles. Piver E, Collin C, Renault N, Bru T, Pagès JC. J Virol; 2006 Oct; 80(19):9889-95. PubMed ID: 16973593 [Abstract] [Full Text] [Related]
9. Development of a novel trans-lentiviral vector that affords predictable safety. Wu X, Wakefield JK, Liu H, Xiao H, Kralovics R, Prchal JT, Kappes JC. Mol Ther; 2000 Jul; 2(1):47-55. PubMed ID: 10899827 [Abstract] [Full Text] [Related]
10. Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cells. Zhang J, Asselin-Paturel C, Bex F, Bernard J, Chehimi J, Willems F, Caignard A, Berglund P, Liljeström P, Burny A, Chouaib S. Gene Ther; 1997 Apr; 4(4):367-74. PubMed ID: 9176524 [Abstract] [Full Text] [Related]
11. Expression of H5N1 influenza virus hemagglutinin protein fused with protein transduction domain in an alphavirus replicon system. Yang SG, Wo JE, Li MW, Mi FF, Yu CB, Lv GL, Cao HC, Lu HF, Wang BH, Zhu H, Li LJ. J Virol Methods; 2010 Jan; 163(1):31-9. PubMed ID: 19646478 [Abstract] [Full Text] [Related]
12. Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines. Withoff S, Glazenburg KL, van Veen ML, Kraak MM, Hospers GA, Störkel S, de Vries EG, Wilschut J, Daemen T. Gene Ther; 2001 Oct; 8(20):1515-23. PubMed ID: 11704811 [Abstract] [Full Text] [Related]
13. Development of a new noncytopathic Semliki Forest virus vector providing high expression levels and stability. Casales E, Rodriguez-Madoz JR, Ruiz-Guillen M, Razquin N, Cuevas Y, Prieto J, Smerdou C. Virology; 2008 Jun 20; 376(1):242-51. PubMed ID: 18442838 [Abstract] [Full Text] [Related]
14. Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses. Kuate S, Stefanou D, Hoffmann D, Wildner O, Uberla K. J Gene Med; 2004 Nov 20; 6(11):1197-205. PubMed ID: 15459964 [Abstract] [Full Text] [Related]
15. Expression of additional genes in a vector derived from a minimal RNA virus. Rolls MM, Haglund K, Rose JK. Virology; 1996 Apr 15; 218(2):406-11. PubMed ID: 8610469 [Abstract] [Full Text] [Related]
16. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector. Guan M, Rodriguez-Madoz JR, Alzuguren P, Gomar C, Kramer MG, Kochanek S, Prieto J, Smerdou C, Qian C. Cancer Res; 2006 Feb 01; 66(3):1620-9. PubMed ID: 16452221 [Abstract] [Full Text] [Related]
17. Development of a novel adenovirus-alphavirus hybrid vector with RNA replicon features for malignant hematopoietic cell transduction. Yang Y, Xiao F, Lu Z, Li Z, Zuo H, Zhang Q, Li Q, Wang H, Wang LS. Cancer Gene Ther; 2013 Aug 01; 20(8):429-36. PubMed ID: 23827880 [Abstract] [Full Text] [Related]
18. Human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins produced from stable packaging cells. Strang BL, Takeuchi Y, Relander T, Richter J, Bailey R, Sanders DA, Collins MK, Ikeda Y. J Virol; 2005 Feb 01; 79(3):1765-71. PubMed ID: 15650201 [Abstract] [Full Text] [Related]
19. Analysis of lenti- and trans-lentiviral vector genetic recombination. Wu X, Wakefield JK, Liu H, Kappes JC. Dev Biol (Basel); 2001 Feb 01; 106():237-48; discussion 249, 253-63. PubMed ID: 11761237 [Abstract] [Full Text] [Related]
20. Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens. Smith ML, Corbo T, Bernales J, Lindbo JA, Pogue GP, Palmer KE, McCormick AA. Virology; 2007 Feb 20; 358(2):321-33. PubMed ID: 17014881 [Abstract] [Full Text] [Related] Page: [Next] [New Search]